Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-05-18

Clinical Trial Update: Safety and Efficacy of Herbmed Plus in Patients withRenal Calculi [Phase 2]

View source ↗

Summary

Clinical trial update on the Phase 2 study of Herbmed Plus for nephrolithiasis, assessing safety and efficacy. The trial status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Herbmed Plus

Snippet

Sponsor: Amai Charitable Trust | Conditions: RENAL CALCULI | Phase 2 | Status: UNKNOWN